Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss
Huntress LA, Fereydooni A, Dardik A, Nassiri N. Endovascular Revascularization Incorporating Infrapopliteal Coronary Drug-Eluting Stents Improves Clinical Outcomes in Patients with Critical Limb Ischemia and Tissue Loss. Annals Of Vascular Surgery 2019, 63: 234-240. PMID: 31563654, DOI: 10.1016/j.avsg.2019.07.011.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAmputation, SurgicalConstriction, PathologicCritical IllnessDrug-Eluting StentsEndovascular ProceduresFemaleHumansIschemiaMaleMiddle AgedPeripheral Arterial DiseasePopliteal ArteryProgression-Free SurvivalProsthesis DesignRetrospective StudiesRisk FactorsTime FactorsUnited StatesVascular PatencyWound HealingConceptsCritical limb ischemiaCoronary drug-eluting stentsDrug-eluting stentsWIfI scoreMajor amputationEndovascular revascularizationClinical outcomesTissue lossPrimary patencyLimb ischemiaMean ankle-brachial indexOne-year primary patencyOne-year survival rateAnkle-brachial indexLimb salvage rateMulti-institutional experienceLevel IA evidenceInfrapopliteal applicationRevascularization benefitTibial revascularizationCause mortalityFoot infectionsInfrapopliteal lesionsArterial atherosclerosisLesion recurrence